Stock Project Joslyn and Lauren 6 th Period. Founded 1990 Founded 1990 The Company is worth $442.8 Million The Company is worth $442.8 Million They named.

Slides:



Advertisements
Similar presentations
Team Dodgers Spring Agenda History Industry Overview Business Model Sources of Competitive Advantage Challenges Initiatives Recommendations.
Advertisements

Stock Market Investment Introduction Session 1A. Session 1 A: Introduction to Equities uWhat are shares and why do companies issue them? uWhere do these.
My Stock Exchange Portfolio Student Name Period ??? Starting Date: Updated on:
FLORIDA INTERNATIONAL TRADE PROGRAMS Manny Mencia Senior Vice President, International Trade & Development Enterprise Florida, Inc. January 15, 2015.
BIOGEN IDEC FRANCE BEST IN FRANCE December 2004 Group C – ES1 Charles Najjar Jonathan Newell Gaku Susai Jaime Arango.
Primedia: “The New Tradition in Media” Beverly Chell Vice Chairman -- Primedia April 27, 2001 Beverly Chell Vice Chairman -- Primedia April 27, 2001.
Patricia E. Scipio, CIA, CPA Vice President, Auditing Wellchoice, Inc. Empire Blue Cross Blue Shield.
Investing in Biotechnology Jessica Yu Biotech 2. Company Description (Week 0 – 7) Genentech, Inc. (DNA) -Goals: Discovering, developing, manufacturing,
Notes Over 7.2 The Substitution Method Use the substitution method to solve the linear system. Solve for x Substitute in for x.
Alan E Smith Senior Vice President Chief Scientific Officer Genzyme MIT R&D Conference November 3rd 2005.
Koji – Clint – Antonio – Jeannette – Rhodora – Brittany.
AMREP Corporation.
JOSHUA BORUCH SECTION /14/09 Kohl’s
 Terry J. Lundgren: Chairman, President and Chief Executive Officer  Macy’s Inc. 7 West Seventh Street Cincinnati, Ohio & 151 West 34 th Street New.
Lee Vala, Senior Vice President of Global Development TAB BOARDS INTERNATIONAL, INC. Joshua Ream, Senior Manager, International Business Development PAPA.
FLIR Systems, Inc.. Nature of Business Design and manufacture thermal imaging and infrared camera systems Sell to commercial, industrial and government.
WHAT KIND OF BUSINESS DOES KAISER PERMANENT DO?  Health Care  Permanent Medical Group  Kaiser Foundation Hospital.
By Jason Williams.
PROPRIETARY AND CONFIDENTIAL INFORMATION OF ADVERTISING.COM, INC. 1 ONLINE MARKETING SOLUTIONS FOR.
“Investing is like gambling, but with better research.”
Company Name Stock Trading Symbol. Company History Founder: Incorporation Date: IPO Date: Initial Sales Price: Current Sales Price:
Doing Business In Thailand
Primedia: “The New Tradition in Media”
Best Social Media Marketing Company
Peter Rohr's Team: A Leading Broker at Merrill Lynch
Finca Allende: A Winery Producing a Variety of Wines
Tiburon Research February 12, 2019
Dow's Port: A Winery Producing a Variety of Wines
Castillo De Perelada: A Winery Producing a Variety of Wines
Broker XYZ's Team: A Leading Private Banker at Merrill Lynch
Charles Lewis' Team: A Leading Bank Broker
Richard Wald's Team: A Leading Broker at Merrill Lynch
John Olson's Team: A Leading Broker at Merrill Lynch
Mark Sear's Team: A Leading Broker at Merrill Lynch
Mark Pollard's Team: A Leading Broker at Merrill Lynch
Dan Osborne's Team: A Leading Bank Broker
Reza Zafari's Team: A Leading Broker at Merrill Lynch
Nestor Vicknair's Team: A Leading Broker at Merrill Lynch
Michael Riherd's Team: A Leading Broker at Merrill Lynch
Fonseca Port Wine: A Winery Producing a Variety of Wines
Mark Wilkins' Team: A Leading Broker at Merrill Lynch
Richard Whiting's Team: A Leading Bank Broker
Kevin Queally's Team: A Leading Broker at Merrill Lynch
Reza Zafari's Team: A Leading Broker at Merrill Lynch
Dean Trindle's Team: A Leading Bank Broker
Alan Zafran's Team: A Leading Broker at Merrill Lynch
Mark Wilkins' Team: A Leading Broker at Merrill Lynch
Gene Vilfordi's Team: A Leading Broker at Merrill Lynch
Broker XYZ's Team: A Leading Private Banker at Merrill Lynch
Gene Vilfordi's Team: A Leading Broker at Merrill Lynch
Stephanie Twomey's Team: A Leading Broker at Merrill Lynch
Dr. Loosen: A Winery Producing a Variety of Wines
Peter Rohr's Team: A Leading Broker at Merrill Lynch
Richard Whiting's Team: A Leading Bank Broker
Nestor Vicknair's Team: A Leading Broker at Merrill Lynch
Contino: A Winery Producing a Variety of Wines
Adega Ponte De Lima: A Winery Producing a Variety of Wines
Phil Scott's Team: A Leading Broker at Merrill Lynch
Yahoo: A Leading Sunnyvale, CA Based Technology Company
Fonseca Port Wine: A Winery Producing a Variety of Wines
Frank Mirabella's Team: A Leading Broker at Merrill Lynch
Contino: A Winery Producing a Variety of Wines
Frank Mirabella's Team: A Leading Broker at Merrill Lynch
Casa Ferreirinha: A Winery Producing a Variety of Wines
The Cavner Team: A Leading Bank Broker
David Waitovich's Team: A Leading Broker at Merrill Lynch
Grao Vasco: A Winery Producing a Variety of Wines
Dow's Port: A Winery Producing a Variety of Wines
Dana Locniskar's Team: A Leading Broker at Merrill Lynch
TradePMR: A Leading Gainesville, FL Financial Institution
Presentation transcript:

Stock Project Joslyn and Lauren 6 th Period

Founded 1990 Founded 1990 The Company is worth $442.8 Million The Company is worth $442.8 Million They named a new Senior Vice President Randall MoreadithPresident They named a new Senior Vice President Randall MoreadithPresident Producers of: Producers of: –NKTR-105 (PEG-docetaxel) –NKTR-063 (inhaled vancomycin) –NKTR-102 (PEG-irinotecan )

1978 scientists gathered in Switzerland and created Biogen 1978 scientists gathered in Switzerland and created Biogen Their goal is to transform scientific discoveries into advances in human healthcare. Their goal is to transform scientific discoveries into advances in human healthcare. They are worth $12.17 Billion They are worth $12.17 Billion Producers of: Producers of: –RITUXAN® (rituximab) –TYSABRI® (natalizumab) –AVONEX® (Interferon beta-1a)

CompanySymbol # of Shares Purchased Stock Value at Purchase($) Current Stock Value ($) Net + or -($) NektarNKTR (+) BiogenBIIB (-)37.85 Total (+)144.15

Producers of: Producers of: – xoliar –Pulmozyme –rapitva Their Trading symbol is DNA Their Trading symbol is DNA Almost bought out by Roche Almost bought out by Roche The company is worth $77.48 Billion The company is worth $77.48 Billion Leading biotech company Leading biotech company

16.5 billion 16.5 billion Producers of: Producers of: – cerazyme –carticle –epicle Henri A. Termeer Chairman of the Board, President Henri A. Termeer Chairman of the Board, President

CompanySymbol# of Shares PurchasedStock Value at Purchase($)Current Stock Value($) Net +or- ($) GenentechDNA (-)22.03 GenzymeGENZ (-)21.95 Total (-)241.93

Biogen Idec, (2008). History. Retrieved December 4, 2008, from biogen.com Web site: Biogen Idec, (2008). History. Retrieved December 4, 2008, from biogen.com Web site: Biogen Idec, (2008). Vision and Values. Retrieved December 4, 2008, from biogen.com Web site: Biogen Idec, (2008). Vision and Values. Retrieved December 4, 2008, from biogen.com Web site: Biogen Idec, (2008). Products on the Market. Retrieved December 4, 2008, from biogen.com Web site: Biogen Idec, (2008). Products on the Market. Retrieved December 4, 2008, from biogen.com Web site: Genentech, (2008). Product Information. Retrieved December 3, 2008, from Genentech Inc. Web site: Genentech, (2008). Product Information. Retrieved December 3, 2008, from Genentech Inc. Web site: Genzyme, (2008). Our Products. Retrieved December 4, 2008, from Genzyme Web site: Genzyme, (2008). Our Products. Retrieved December 4, 2008, from Genzyme Web site: Nektar, (2008). Media room. Retrieved December 4, 2008, from Nektar.com Web site: Nektar, (2008). Media room. Retrieved December 4, 2008, from Nektar.com Web site: Nektar, (2008). Nektar Therapeutics. Retrieved December 4, 2008, from nektar.com Web site: Nektar, (2008). Nektar Therapeutics. Retrieved December 4, 2008, from nektar.com Web site: Nektar, (2008). Nektar Proprietary Products. Retrieved December 4, 2008, from Nektar.com Web site: Nektar, (2008). Nektar Proprietary Products. Retrieved December 4, 2008, from Nektar.com Web site: Yahoo, (2008). Yahoo Finance. Retrieved December 3, 2008, from Genentech Inc. Web site: Yahoo, (2008). Yahoo Finance. Retrieved December 3, 2008, from Genentech Inc. Web site: